-
GW 6471: From Target Validation to Assay Design
2026-09-04
GW 6471 is a PPARα antagonist that can convert pathway association into a testable causal model. This article explains how to use it with transcriptomic, biochemical, and morphological endpoints in cellular metabolism research and zebrafish toxicology.
-
Puromycin aminonucleoside for Podocyte Injury
2026-09-04
Puromycin aminonucleoside enables controlled podocyte injury, proteinuria, and glomerular pathology studies across cell and animal workflows. This guide translates its nephrotoxic activity into practical assay design, dose-ranging, phenotype validation, and troubleshooting strategies.
-
cGAMP Efflux: Reframing STING in Radiotherapy
2026-09-04
Radiotherapy-induced DNA damage can activate cGAS-STING signaling, but new evidence shows that cGAMP export may actively shape radioresistance. This thought-leadership article explains how 2'3'-cGAMP (sodium salt) can serve as a receptor-proximal mechanistic probe for distinguishing STING competence, cGAMP trafficking, and translational response.
-
Nutlin-3a MDM2 Inhibitor Workflow
2026-09-03
Nutlin-3a provides a controllable way to activate p53, measure cell cycle arrest, and distinguish apoptosis from broader stress responses. This workflow also shows how to extend MDM2-p53 experiments into glioblastoma ferroptosis and migration studies without overstating evidence.
-
DiR (DiIC 18 (7)) for Long-Term Membrane Imaging
2026-09-02
DiR, also called DiIC 18 (7), is a deep-red lipophilic probe for cell membrane staining, fixed tissue membrane labeling, and long-term tracking. Its near-infrared signal supports low-background imaging, while the product specifications define solvent, storage, purity, and stability limits.
-
Human iPSC Hepatobiliary Organoids: Study Insights
2026-09-02
Wu et al. established a staged, cell-free and non-genetically modified method for generating hepatobiliary organoids from human induced pluripotent stem cells. The resulting 3D tissues combined hepatocyte-like and biliary characteristics, offering a useful platform for studying liver development, drug metabolism, and disease modeling while highlighting important limits in organoid maturity and transferability.
-
SOD Activity Assay: Practical Guide to K2035
2026-09-01
Learn how SKU K2035 supports reproducible SOD activity detection when viability, proliferation, or cytotoxicity results are difficult to interpret. This scenario-based guide covers assay chemistry, controls, protocol parameters, data normalization, and practical product selection.
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-09-01
α-Bungarotoxin provides a high-affinity way to test whether α7 nicotinic acetylcholine receptor signaling drives a cellular phenotype. This article translates its use from receptor pharmacology into practical workflows for cholinergic inhibition, neurotoxicity research, and placental necroptosis studies.
-
L-NAME Hydrochloride in NO Research
2026-08-31
L-NAME Hydrochloride provides a practical, reversible way to interrogate nitric oxide synthase activity across vascular, cellular, and renal injury workflows. This guide connects dose-finding, orthogonal readouts, L-arginine rescue, and the FXR–KLF11 kidney-protection study to help distinguish NO-dependent effects from broader stress signaling.
-
Human iPSC Hepatobiliary Organoids: Study Insights
2026-08-31
Wu and colleagues developed a three-dimensional hepatobiliary organoid system from human induced pluripotent stem cells without exogenous support cells or genetic manipulation. The model reproduced complementary hepatocyte-like and biliary functions, providing a useful platform for studying liver development, disease mechanisms, and drug responses.
-
Making Lipogenic Biology Visible with Cy3 TSA
2026-08-30
A translational framework for using tyramide signal amplification to map the SIX1–DNL axis in liver cancer and strengthen spatial biomarker validation.
-
Angiotensin (1-7): Reliable Cell Assay Design
2026-08-29
A scenario-based guide to using Angiotensin (1-7), SKU A1041, in cell viability, proliferation, and cytotoxicity workflows. It connects Mas receptor biology with formulation, controls, dose selection, interpretation, and supplier-quality decisions.
-
Axitinib (AG 013736): Practical Assay Workflows
2026-08-28
Axitinib (AG 013736) enables precise VEGFR-focused studies spanning endothelial signaling, angiogenesis inhibition assay design, and tumor models. This workflow-driven guide shows how to separate pathway blockade from general cytotoxicity, improve dose-response reproducibility, and troubleshoot solubility or endpoint problems.
-
Gasdermin C Rewires PDAC Stemness and Immunity
2026-08-28
A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a nuclear regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion, rather than solely a pore-forming pyroptosis protein. The work links ADAM17-dependent cleavage and nuclear translocation of GSDMC to aggressive tumor phenotypes and shows that GSDMC targeting can improve responses to KRASG12D inhibition and PD-1 blockade in preclinical models.
-
BMAL1 Phase Separation and Circadian Transcription
2026-08-27
Gao and colleagues identify BMAL1 as a phosphorylation-tunable phase-separating protein that forms nuclear transcriptional hubs with CLOCK, p300, MED1, and E-box DNA. The study connects condensate formation with rhythmic gene expression and behavioral clock function, offering a mechanistic explanation for the delay between BMAL1 chromatin occupancy and transcriptional output.